Crown Street, Wollongong, 2500
The Cost of Compliance: Why Doing It Right in Cosmetic Marketing Feels Like Losing, and Why It Isn't
Melody Jaimon • September 18, 2026
A few weeks ago I sat down and went through a stack of Australian cosmetic clinic websites, checking them against the current TGA and AHPRA advertising rules. Not as an academic exercise. I was doing remediation work for a client, and while I had her site open, I started clicking through competitors in the same space.
What I found annoyed me: sites naming prohibited terms outright- Botox, fillers, Profhilo, and similar- all of it sitting there, indexed, ranking, booking out calendars. A common misconception in the industry is that this is somehow safer for doctors than for nurses, since a doctor can say these words directly to a patient in a private consultation. It doesn't work that way. The TGA's exception under section 42AA covers doctors and registered nurses alike; either can name a brand inside a genuine one-on-one consultation, but neither can publish it on a public web page designed to attract bookings. The rule isn't about who's speaking; it's about whether the audience is one identified patient or the public at large, and plenty of sites getting this wrong had nothing to do with the practitioner's qualifications. Meanwhile, my client's site had just been through a careful, page-by-page rewrite to strip out exactly that kind of content.
As a leading web design and marketing agency in Australia, we support a diverse range of businesses across the country, including cosmetic clinics. Cosmetic clinic website design is one of the areas we've spent the most time in recently, largely because so few agencies are keeping pace with how fast this regulatory space is moving.
That's the genuinely frustrating part of this space right now. The clinics doing the right thing are the ones spending money and time making their websites less specific, less searchable, less immediately satisfying to a confused potential patient. The clinics ignoring the rules are the ones showing up in the search results those patients are actually typing.
It feels backwards. But it isn't a reason to cut corners, and it isn't as safe a bet as it looks for the clinics doing it.
The rules aren't ambiguous, even when the workarounds look clever.
The confusion in this space usually isn't about whether a rule exists. It's about whether a particular way of dancing around it counts as breaking it. Clinics (and, increasingly, their marketing agencies) come up with genuinely creative ways to imply a named, restricted product without technically naming it: initials, "the brand starting with P", injection protocols specific enough that anyone who's researched the product for five minutes knows exactly what's being described.
The TGA has already closed that door, and it did so in plain language. Its own advertising FAQ states that references to a restricted product "however made" are treated as advertising that product. Not "if you name it directly." However made. A description detailed enough to identify the product functions as an identifier, whether or not a brand name appears on the page.
Profhilo is the TGA's own example. It contains hyaluronic acid at a concentration that places it under Schedule 4, and the TGA has stated plainly that clinics can't advertise it to the public, regardless of the words used to dance around the name.
Why this actually hurts patients too
Here's the part that doesn't get talked about enough. This isn't only a marketing headache. Patients researching these treatments are genuinely trying to work out which option addresses their concern, and the rules (correctly, for public safety reasons) prevent clinics from laying that out clearly on a public website using brand names.
That pushes people towards generic terms like "injectable hydration" or "bio-remodelling" that all sound the same, or towards competitor sites that have ignored the restrictions and will happily spell out exactly what's in the syringe. Neither is a great outcome. The compliant clinic ends up harder to understand. The non-compliant one ends up rewarded with the traffic.
Why "getting away with it" is not the same as being safe
It's tempting to see a competitor ranking well with non-compliant content and assume the rules aren't really being enforced. The data says otherwise.
AHPRA logged 380 advertising complaints in 2022–23, with 65 non-compliance findings from a targeted audit of cosmetic advertising. Anyone can lodge complaints anonymously and at no cost, including a competitor clinic. AHPRA's advertising guidelines set the maximum penalty for a breach at $120,000 for a corporation and $60,000 for an individual practitioner, per breach, not per website.
The TGA acts directly too, and keeps a public register of every infringement notice it issues. In December 2025, a Queensland-based individual was issued two infringement notices totalling $7,716 for unlawfully advertising prescription-only cosmetic injectables to the public via social media. That's not a warning letter. That's a published, named outcome.
None of this requires a regulator to go looking. It just requires one competitor, one former patient, or one member of the public with five minutes and a complaint form.
What compliance actually looks like in practice
This isn't a theoretical exercise for us. We worked through exactly this problem for a Bowral cosmetic clinic client. During a content review, we flagged that their site was naming a restricted product directly. The fix wasn't complicated once we knew what we were solving for:
- The restricted product's page was rewritten entirely around what the treatment does: hydration, firmness, facial structure, with no brand name and no identifying detail like injection technique or formula specifics
- Every other page linking to it was checked and updated to match, because a leftover reference on one concern page is just as much a breach as one on the homepage.
- Products assumed to carry the same restriction were checked against the TGA's public register, the ARTG, before being ruled in or out, rather than guessed at. Two of them turned out to be registered medical devices, not scheduled medicines, and could be named freely once that was confirmed.
- New blog content covering the same treatments was written to the same standard from the start, not patched afterwards.
The result is a site that still explains the differences between treatments clearly enough for a patient to make an informed choice, without naming anything it isn't allowed to name.
If you're not sure where your own site sits
Most non-compliant content on clinic websites isn't the result of anyone trying to cheat the system. It's old copy that predates a rule change, a page nobody's revisited since the last rewrite, or a well-meaning workaround that doesn't hold up against "however made." The fix is usually a content audit, not a full rebuild.
If you run a cosmetic or aesthetic clinic and you're not confident every page and every blog post on your site would hold up against a TGA or AHPRA review, that's worth checking properly rather than assuming it's fine because nobody's complained yet. If you'd like your site copy audited, this is exactly the kind of work we do.
Melody Jaimon is the founder of Love My Online Marketing and a member of the Australasian Medical Writers Association (AMWA).
Love My Online Marketing has 10+ Years of working alongside businesses and helping them grow. Discuss your options for online success from website Design and Development through to Google Marketing.
Do you want more traffic and business leads?
Love My Online Marketing is determined to make a business grow. Our only question is, will it be yours?
